Human Factor Va1 and Factor Va2: Properties in the Procoagulant and Anticoagulant Pathways
- 1 March 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 36 (11), 3331-3335
- https://doi.org/10.1021/bi9623284
Abstract
Human plasma factor V is heterogeneous and yields two forms of activated factor V that bind with low (factor Va1) and high affinity (factor Va2) to phospholipids. The properties of factor Va1 and factor Va2 in the anticoagulant and procoagulant pathways were evaluated by comparing their sensitivity for inactivation by APC and their ability to act as cofactor in prothrombin activation. At low phospholipid concentrations and on membranes containing low amounts of phosphatidylserine (PS), factor Va1 was inactivated by APC at 15-fold lower rates than factor Va2, both in the absence and in the presence of protein S. At high phospholipid concentrations and on membranes with more than 15 mol % PS, factor Va1 and factor Va2 were inactivated with equal efficiency. Differences between cofactor activities of factor Va1 and factor Va2 in prothrombin activation were only observed on membranes with less than 7.5 mol % PS. Due to the different phospholipid requirements of APC-catalyzed factor Va inactivation and of expression of factor Va cofactor activity in prothrombin activation, the thrombin-forming capacity of factor V1 was 7-fold higher than that of factor V2 in a reaction system containing factor Xa, prothrombin, APC, protein S, vesicles with a phospholipid composition resembling that of activated platelets, and traces of thrombin to initiate prothrombin activation. This shows that in the process of generation, expression, and down-regulation of factor Va cofactor activity on physiological membranes, the overall procoagulant activity of factor V1 can considerably exceed that of factor V2.Keywords
This publication has 14 references indexed in Scilit:
- Effects of Protein S and Factor Xa on Peptide Bond Cleavages during Inactivation of Factor Va and Factor VaR506Q by Activated Protein CPublished by Elsevier ,1995
- Characterization of the Molecular Defect in Factor VR506APublished by Elsevier ,1995
- The mechanism of inactivation of human factor V and human factor Va by activated protein C.Journal of Biological Chemistry, 1994
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras.Journal of Biological Chemistry, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein CEuropean Journal of Biochemistry, 1992
- Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma.Journal of Biological Chemistry, 1991
- The Roles of Protein C and Thrombomodulin in the Regulation of Blood CoagulationJournal of Biological Chemistry, 1989
- Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection.Journal of Biological Chemistry, 1988